FDA beefs up its science staff (EETimes)
The Food and Drug Administration is bolstering its scientific capabilities in the face of accelerating technology change and market globalization, said the agency's newly appointed chief scientist in a keynote address at the Biomed Device conference.

MiCardia Corporation Receives US FDA Market Clearance For Dynaplasty Annuloplasty Devices (Medical News Today)
MiCardia Corporation announced that the U.S. Food and Drug Administration ("FDA") has granted 510(k) marketing clearance for its Dynaplasty Annuloplasty Band DR and Annuloplasty Ring DR. These are the first of MiCardia's innovative Dynaplasty Technology products to receive clearance.